Rights:
Atribución-NoComercial-SinDerivadas 3.0 España
Abstract:
Melanoma is the most dangerous form of skin cancer and it has a
very low survival rate when treated in advanced stages. However, the
prognosis is much more hopeful if it is detected in early stages. Dermoscopy
is a well known skin lesion visualization technMelanoma is the most dangerous form of skin cancer and it has a
very low survival rate when treated in advanced stages. However, the
prognosis is much more hopeful if it is detected in early stages. Dermoscopy
is a well known skin lesion visualization technique which
reveals many structural details that are hidden to the naked eye without
the need of taking a biopsy. There is an increasing interest in the
development of computer-aided systems to assist the clinicians in their
diagnosis of this form of cancer using dermoscopy. However, despite
of the many research efforts devoted to this matter, these systems have
not yet been incorporated into the daily clinical practice. One of the
underlying reasons for this lack of success is that most of the systems
simply provide a parallel diagnosis to the clinicians, which actually
does not help them in practice. Although very powerful in terms of
classification accuracy, most of these systems lack a clear understanding
of the main underlying factors and lesion properties that support
their final decision. This causes the clinicians not to trust the output of
these automatic systems.
In this Ph.D. Thesis, we have proposed two Computer-aided Diagnosis
systems for early melanoma detection. Our first approach aims
to go beyond a simple diagnosis suggestion, to provide enriched information
about its automatic diagnosis. We have designed a novel set
of clinical-based features, which are based on both dermoscopic structures
and diagnosis criteria from dermoscopic algorithms. The medical
basis allows these features to show both competitive performance in
melanoma detection and at the same time good interpretability for
dermatologists. Moreover, we have focused on obtaining quantitative
measures of clinical criteria, which provides clinicians with additional
information to perform lesion diagnosis. In order to present this information
to the clinician, we have designed an automatic tool. It shows
the segmentation into the dermoscopic structures that are present in
the lesion, together with the weight of each structure-based expert on
the final decision and the features having stronger influence in the
decision of each expert.
The performance of the first system has been assessed in two scenarios.
On the one hand, we use a dataset containing difficult cases for
dermatologists, in order to emulate the behavior of our system in the
clinical practice of an expert clinician. In this case, it has been shown
that there is a boost in performance when combining our system with
the diagnosis of an expert dermatologist, which demonstrates the usefulness
of the system as a support element to the decisions of dermatologists.
On the other hand, our approach improves the performance
of quite a few competent methods from the state-of-the-art. Although
it provides results just close to those of CNN-based methods, it offers
an understandable interface for clinicians, so they can obtain complementary
information and know the main reasons that led the system
to make its diagnostic decision.
Our second proposal is based on CNNs, since these algorithms have
shown to be more powerful than classical approaches in many Computer
Vision scenarios, including skin lesions diagnosis. Although their
interpretability is very limited in comparison with a classical system,
some efforts can be made in this direction so the systems become more
practical and not only better in terms of performance. According to this
idea, we have adapted the architecture of a typical image classification
network to incorporate dermoscopic structures explicitly, in order to
guarantee their contribution to the diagnosis suggestion. To this purpose,
we have used a structure segmentation network to obtain the
dermoscopic structure maps, which are then fed to a diagnosis network.
The diagnosis network considers both the original dermoscopic
image and the structure maps, and yields a diagnosis proposal.
The proposed segmentation network is able to learn from both strong
and weak labels, using a hybrid loss function. In our experiments, we
have checked the segmentation performance using different proportions
of strong and weak labels. The results show that, once a minimum
number of strongly-labeled examples are gathered, the rest of the effort
can be allocated to obtaining weakly-labeled samples. Weak labels
are cheap to obtain for a dermatologist, while strong labels are much
more costly. This implies that the cost of building a database for dermoscopic
structure segmentation should be reduced. With a correct
balance between weak and strong labels, the performance would not be
significantly affected.
Regarding the diagnosis network, it is formed by a main network,
which receives the dermoscopic image of the lesion, and an auxiliary
network that gets the structure segmentations and builds feature representations
to incorporate this information at several selected locations
of the main network. Our experimental results show that the
proposed method provides better average results than a selected set
of state-of-the-art methods. Furthermore, it also outperforms two relevant
ensemble-based methods from the ISIC challenge (an important
international contest on melanoma diagnosis using dermoscopic images),
which suggests that the diagnosis information embedded into
the dermoscopic structures is not properly inferred by the learned features
of general purpose architectures, even for very complex models.
Moreover, the proposed system improves the results of other state-ofthe-
art methods in terms of specificity at 95% sensitivity, which is a
performance measure well adapted to the practical daily problem of
filtering benign lesions for having the doctors focused on suspicious
lesions.[+][-]